Blocking TLR2 activity attenuates pulmonary metastases of tumor. - Test2 - elhamkhani - TriplyDB

Blocking TLR2 activity attenuates pulmonary metastases of tumor.

Blocking TLR2 activity attenuates pulmonary metastases of tumor.

http://www.wikidata.org/entity/Q33490618

about

Timing is critical for an effective anti-metastatic immunotherapy: the decisive role of IFNγ/STAT1-mediated activation of autophagy Toll-like receptor (TLR) 2 and TLR4 differentially regulate doxorubicin induced cardiomyopathy in mice.Gene silencing of Toll-like receptor 2 inhibits proliferation of human liver cancer cells and secretion of inflammatory cytokines Targeting acute myeloid leukemia with a proapoptotic peptide conjugated to a Toll-like receptor 2-mediated cell-penetrating peptide.CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain Antagonism of toll-like receptor 2 attenuates the formation and progression of abdominal aortic aneurysm.Effect of myeloid differentiation primary response gene 88 on expression profiles of genes during the development and progression of Helicobacter-induced gastric cancer Discovery of small-molecule inhibitors of the TLR1/TLR2 complex TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue.Vaccine-induced but not tumor-derived Interleukin-10 dictates the efficacy of Interleukin-10 blockade in therapeutic vaccination.Interleukin 17A inhibits autophagy through activation of PIK3CA to interrupt the GSK3B-mediated degradation of BCL2 in lung epithelial cells.Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver.Distinct subpopulations of epithelial ovarian cancer cells can differentially induce macrophages and T regulatory cells toward a pro-tumor phenotype The regulation of Toll-like receptor 2 by miR-143 suppresses the invasion and migration of a subset of human colorectal carcinoma cells.Chlamydia pneumoniae infection promotes vascular smooth muscle cell migration through a Toll-like receptor 2-related signaling pathway.Simultaneous TLR2 inhibition and TLR9 activation synergistically suppress tumor metastasis in mice.Toll-like receptors: Role in inflammation and therapeutic potential.Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer.Combined treatment with X-ray irradiation and 5-aminolevulinic acid elicits better transcriptomic response of cell cycle-related factors than X-ray irradiation alone.Sepsis-induced expansion of granulocytic myeloid-derived suppressor cells promotes tumour growth through Toll-like receptor 4.Molecular mechanisms involved in dendritic cell dysfunction in cancer.Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.Gram negative bacteria increase non-small cell lung cancer metastasis via Toll-like receptor 4 activation and mitogen-activated protein kinase phosphorylation.miR-154 suppresses colorectal cancer cell growth and motility by targeting TLR2.Redundant and regulatory roles for Toll-like receptors in Leishmania infection.Gram-positive pneumonia augments non-small cell lung cancer metastasis via host toll-like receptor 2 activation.Phase I study of a chloroquine-gemcitabine combination in patients with metastatic or unresectable pancreatic cancer.Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice.Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.The effect of monotherapy and combined therapy with NSC-631570 (ukrain) on growth of low- and high-metastasizing B16 melanoma in mice.Staphylococcus aureus modulation of innate immune responses through Toll-like (TLR), (NOD)-like (NLR) and C-type lectin (CLR) receptors

P2860

Q34023964-35B044B4-E1CB-4C9C-A2BD-4065C7DCDC6D Q34342389-4D41BAC6-3DDF-4201-A01E-B3606F50BFF9 Q34344636-D798E700-9A3D-48FE-9BA4-33364C6219CC Q34818576-8B089F31-1F10-4751-8984-BF00470D699A Q35485418-92CE00E0-D658-49F1-BCC3-42DC7F21BE3B Q35567140-F8532D5E-DB00-4116-9E41-ADEC1C83F83D Q36237998-EF582874-CC4D-4564-B607-83CD9CB712EA Q36281632-0D275747-CC82-4C2C-90A3-4E61808234A5 Q36434517-EA4AF191-2885-4B24-B5FF-AC0BD606F006 Q36654413-B4A1C5C4-3A93-4C04-B48B-183555548BCA Q36671862-C13682E5-7573-4A2D-AE0A-6E5F3431A742 Q36710936-E9B2DBE1-C7C5-45DB-8802-FAE48F19BBB0 Q36892083-73629BD3-D685-4EBE-91FD-5DF9A8621719 Q36970905-6B77DB01-16A2-4A39-B625-A9531B53CEF8 Q36999077-91DDF841-C561-4A8A-9BC8-51C42D3AE71E Q37113195-9F6F67BA-E709-408A-8D20-060F5E286715 Q37336070-6BE74FE2-B933-4334-AC3C-EFCFB13DC54C Q37729944-73267B16-8133-4DC6-896A-48DDD107286B Q38174528-BF0DD6E7-A0E5-496D-9FC0-7D52E88B21EE Q38704340-C8ECEDAB-21EF-4A42-97EA-448C18278B9F Q38748644-1DFDD0AA-B1B3-47A2-BE2A-D940242F924D Q38771038-F76364CE-0649-41D1-8973-CCE2B36E001A Q38918609-81DBCC48-8651-4CC6-9F72-1F36129363E4 Q38945757-704CCF7C-7D42-4A64-95D0-EA71ED744FEE Q38969650-C896C3F9-E027-4EE8-B375-2AA59BFDEFAA Q39062255-7E7A598F-0572-4DC7-A13E-5BA5E9A7BEFD Q39435029-9C0C4E73-3F88-4C1E-82B1-2FA2B0303C1D Q40254726-1D53E260-D3D6-4100-96E7-E07D4D82E2D4 Q41911824-0DE07FDF-9660-496C-A1A7-512B4F26F948 Q43771802-83B87529-1DF0-4C4B-BC1F-7EF431E2C392 Q53266736-4BAAD613-9BC3-4990-9597-735C58834D6F Q53302359-42FF57BA-A51C-4163-A5DB-51E461877707 Q57163788-FFE130EF-D345-4ED0-B26B-204E4964FA51

P2860

Blocking TLR2 activity attenuates pulmonary metastases of tumor.

http://www.wikidata.org/entity/Q33490618

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Blocking TLR2 activity attenuates pulmonary metastases of tumor.

@ast

Blocking TLR2 activity attenuates pulmonary metastases of tumor.

@en

type

label

Blocking TLR2 activity attenuates pulmonary metastases of tumor.

@ast

Blocking TLR2 activity attenuates pulmonary metastases of tumor.

@en

prefLabel

Blocking TLR2 activity attenuates pulmonary metastases of tumor.

@ast

Blocking TLR2 activity attenuates pulmonary metastases of tumor.

@en

P1433

Q33490618-13BD915D-5B09-4786-BC86-E53C47F79388

P1476

Q33490618-4EF52081-11AF-42D0-A2B7-4100D4A8B6D7

P2093

Q33490618-0714673E-2FC0-4FE1-9519-757415F128AA

Q33490618-0E7293AB-F4FC-45DA-A691-D7BB8F633743

Q33490618-0FF15AB7-2022-4E16-8518-A9432753CBF3

Q33490618-2D2E0B6C-0124-4D4E-9CAA-DFFA260395E7

Q33490618-3B5E2394-6623-4CAC-83A6-AAA208EB5717

Q33490618-86B305DB-B30E-4B6E-B410-86F6B2686E3B

Q33490618-8A71F361-B65A-416F-93CB-A80EA421C3F8

Q33490618-90BC1674-73E1-4910-94C5-3AFF86A03F4F

Q33490618-9E53283D-96D1-457F-8BE7-B58B2ECC1E5F

Q33490618-9FAD1AF7-0C53-419B-B67C-E7D2B1155FD8

P2860

Q33490618-00DAF890-FA96-4DEC-BCE4-45670AEC6F1C

Q33490618-0DA45AB7-3026-4A4D-A4B4-EB127894BE24

Q33490618-1A05AFCC-32CB-47B3-B558-B508EB4A1EEF

Q33490618-1A9FE39D-19A7-4BB1-BFF3-8EF48F531D5D

Q33490618-1DC4673D-AA0C-42CA-9251-8FF230032AB1

Q33490618-33F1C3E7-49CA-4E04-B373-6662AE60D248

Q33490618-461C6C13-A278-41C5-9457-9BC09DA539C0

Q33490618-5C05480A-4591-4508-B61C-9EC8EF1971A6

Q33490618-625CE972-B17A-45B8-9FE9-58D1FB30B00E

Q33490618-65D9A813-7024-4F24-BCC7-5678717C22E3

P304

Q33490618-CC67CCBA-6205-4C5A-A0AD-3A8F30EC7012

P31

Q33490618-C4C6817A-C106-48DE-AC53-7914DC91266B

P356

Q33490618-8A18C6E0-2A20-4F1B-B2C3-ECC2D3DA77B5

P407

Q33490618-A3FD9E64-0337-40DF-A490-B330DACE43BA

P433

Q33490618-8589125D-04CF-4ECB-972C-BEBABD4A7F81

P478

Q33490618-979CE18D-B776-40F4-941A-643CF705E088

P50

Q33490618-58A65664-D278-442D-B2D7-F710A03EC44D

P577

Q33490618-8FE57693-7400-4CF9-9A7B-5BB76A144D42

P5875

Q33490618-AE0641A3-653E-4D00-A6C4-A226714AE942

P698

Q33490618-1C438645-92F9-4734-93A6-BB6F15FEFD8E

P921

Q33490618-2211FE69-E04E-434E-BBFF-5D2FADE0CC00

P932

Q33490618-F042408F-F284-483A-BB26-E47D450C5802

P356

JOURNAL.PONE.0006520

P1433

P1476

Blocking TLR2 activity attenuates pulmonary metastases of tumor.

@en

P2093

Bing-Mu Xin

http://www.w3.org/2001/XMLSchema#string

Fang Hua

http://www.w3.org/2001/XMLSchema#string

Han-Zhi Liu

http://www.w3.org/2001/XMLSchema#string

Heng Lin

http://www.w3.org/2001/XMLSchema#string

Hong-Zhen Yang

http://www.w3.org/2001/XMLSchema#string

Hui-Min Yan

http://www.w3.org/2001/XMLSchema#string

Jun Yan

http://www.w3.org/2001/XMLSchema#string

Qi-Min Zhan

http://www.w3.org/2001/XMLSchema#string

Su Mi

http://www.w3.org/2001/XMLSchema#string

Wen-Feng Cai

http://www.w3.org/2001/XMLSchema#string

P2860

HMGB1 mediates endogenous TLR2 activation and brain tumor regression

Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury

Macrophage-activating lipopeptide-2 (MALP-2) induces a localized inflammatory response in rats resulting in activation of brain sites implicated in fever

Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis

Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix

Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large.

Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors.

Tregs and rethinking cancer immunotherapy.

Thymosin alpha 1: from bench to bedside.

P304

e6520

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0006520

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-08-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26717082

http://www.w3.org/2001/XMLSchema#string

P698

19654875

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

2716531

http://www.w3.org/2001/XMLSchema#string